While the pre-COVID prevention funding system had been extremely successful in the past 20 years in reducing communicative disease deaths globally, it has not been able to reduce non-communicative disease (NCD) and injury mortality.
There are many effective programs which can save lives and costs from these burdens – such as programs preventing pre-diabetic progression to diabetes, stroke, avoidable blindness, mental disorders and neonatal diseases.
For examples of proven public policy interventions see research such as Assessing Cost Effectiveness in Prevention, which shows how to prevent NCD burden while saving costs. In that publication, the dominant interventions would save a net $6.4 billion in responsive healthcare costs.